Related Experiment Videos
Posterior reversible encephalopathy syndrome in a child with bronchial asthma
Hirokazu Kurahashi1, Akihisa Okumura, Teruko Koide
1Department of Pediatrics, Nagoya University Graduate School of Medicine, Aichi, Japan. hiro-k@med.nagoya-u.ac.jp
Insights
Posterior reversible encephalopathy syndrome (PRES) is a rare adverse event linked to steroid treatment for severe asthma. This case highlights the importance of monitoring for PRES in pediatric patients receiving corticosteroids.
Area of Science:
- Neurology
- Pediatrics
- Pulmonology
Background:
- Posterior reversible encephalopathy syndrome (PRES) is a neurological condition associated with various underlying causes.
- Bronchial asthma management often involves corticosteroid therapy, a known risk factor for PRES.
- No prior reports have documented PRES specifically in association with bronchial asthma.
Observation:
- A 4-year-old girl with severe asthmatic attack received corticosteroid treatment.
- She developed hypertension, pulmonary edema, and cardiomegaly, followed by lethargy and generalized convulsions.
- Neuroimaging revealed characteristic PRES findings in the bilateral occipital white matter.
Findings:
- The patient presented with clinical and radiological evidence of PRES during corticosteroid therapy for asthma.
- Discontinuation of corticosteroids and antihypertensive management led to clinical improvement.
- Follow-up imaging showed complete resolution of PRES, with no neurological sequelae observed at two years.
Implications:
- This case underscores that PRES is a rare but significant adverse event associated with corticosteroid therapy.
- Physicians should maintain a high index of suspicion for PRES in pediatric patients with asthma receiving steroids, especially if hypertension or neurological symptoms arise.
- Awareness of steroid-induced hypertension and water retention is crucial for early PRES detection and management.
Abstract:
Although posterior reversible encephalopathy syndrome (PRES) is caused by various conditions, there have been no reports on PRES associated with bronchial asthma. We report a case with PRES during the treatment for severe asthmatic attack. A 4-year-old girl was treated for asthmatic attack with steroids. From the 10th hospital day, hypertension, pulmonary edema, and cardiomegaly were observed. In spite of treatment with furosemide, she became lethargic and had a generalized convulsion on the 23rd hospital day. CT showed low density areas in the bilateral occipital white matter and MRI on the 28th hospital day demonstrated high intensity areas in the same regions on T2-weighted and FLAIR images. After discontinuation of corticosteroid and further antihypertensive therapy, her consciousness improved. MRI on the 67th hospital day had no abnormalities and no neurological sequelae were seen at 2 years after the event. We should be aware that PRES is a rare but important adverse event related to steroid therapy, because hypertension and water retention are major adverse effects of steroids.
Related Concept Videos
Asthma I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Encephalitis l: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Respiratory Syncytial Virus Disease